Trending

24/7 Market News – (NASDAQ: NRSN) Neurosense Therapeutics Inc. Shares are up more than 20% after the open on 9 mil in volume and climbing.

The company releases a 6k announcing positive results of the in-life phase of its toxicology study. Shares are at $3.09 on more than 36,000 trades.

https://neurosense.investorroom.com/sec-filings

RelatedNews

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist